Tag: methadone

Home methadone
Methadone Monopoly and the Theft of Public Funds - How a Few Profit While America Stays Hooked
Post

Methadone Monopoly and the Theft of Public Funds: Few Profit While America Stays Hooked

America’s methadone maintenance system has become a multi-billion-dollar behemoth, fueled by taxpayer subsidies that keep people dependent on opioids rather than fostering genuine recovery. This article exposes how a privileged few profit while crucial community services—mental health care, physical therapy, and nutrition—go underfunded. It calls for redirecting resources into comprehensive support that addresses the root causes of addiction, challenging the deeply entrenched profit motives that dominate American healthcare.

Methadone at IG Farben - Gustav Ehrhart - Max Bockmühl
Post

Methadone at IG Farben—Gustav Ehrhart & Max Bockmühl

During the late 1930s, Gustav Ehrhart and Max Bockmühl, both research chemists working at IG Farben’s Hoechst laboratories, successfully synthesized a novel compound later known as methadone. Although initially developed to mitigate Germany’s reliance on imported opiates, methadone’s significance would transcend its wartime origins, ultimately emerging as a crucial medication in modern pain management and opioid dependence treatment. Despite the obscurity of their personal histories, Ehrhart and Bockmühl’s pioneering achievement demonstrates how scientific discovery can evolve far beyond the political and historical circumstances of its inception, offering vital therapeutic benefits to countless patients worldwide.